Gilead Sciences funds research on multi-specialty care models to improve Hepatitis C outcomes in pregnant patients, focusing on treatment initiation and post-treatment follow-up.
Funder: Gilead Sciences
Due Dates: Rolling (applications accepted until funds are exhausted)
Funding Amounts: Budget not specified; funding based on concept merit and available funds.
Summary: Supports research on care models to improve Hepatitis C outcomes in pregnant patients, focusing on multi-specialty coordination, linkage to care, and treatment initiation.
Key Information: Open to all geographies; applications reviewed on a rolling basis as a Topic of Interest, not a time-limited RFP.
This opportunity from Gilead Sciences supports externally sponsored research focused on advancing clinical and implementation science for Hepatitis C, with a particular emphasis on pregnant patients. The initiative seeks to develop and evaluate practical, scalable care models that improve identification, linkage to care, and treatment initiation for HCV-positive pregnant patients through coordinated, multi-specialty approaches. Projects should also generate evidence on post-treatment follow-up and maternal or postpartum outcomes, aiming to inform best practices and scalable strategies for Hepatitis C care during pregnancy.